{"result": "(\"entity\"<|>CÓRDOBA<|>GEO<|>Córdoba is a city in Spain where the Hospital Universitario Reina Sofía is located, and where the bariatric surgery took place.)\n##\n(\"entity\"<|>OBESIDAD MÓRBIDA<|>EVENT<|>Obesidad mórbida is a medical condition characterized by excessive body weight that poses health risks, which was present in the patient prior to surgery.)\n##\n(\"entity\"<|>INSULINODEPENDIENTE<|>EVENT<|>Insulinodependiente refers to the patient's condition of being dependent on insulin for managing diabetes mellitus type 2.)\n##\n(\"entity\"<|>DEHISCENCIA DE SUTURA<|>EVENT<|>Dehiscencia de sutura is a complication that occurred post-bariatric surgery, involving the reopening of a surgical wound.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL TOTAL<|>EVENT<|>Nutrición enteral total is a method of feeding that bypasses the usual process of eating and digestion, used in the patient's post-operative care.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL TOTAL<|>EVENT<|>Nutrición parenteral total is a method of feeding that provides nutrients directly into the bloodstream, used when the patient could not take food orally.)\n##\n(\"entity\"<|>SOPORTE NUTRICIONAL<|>EVENT<|>Soporte nutricional refers to the nutritional support provided to the patient during recovery after surgery.)\n##\n(\"entity\"<|>SÍNDROME DEPRESIVO<|>EVENT<|>Síndrome depresivo refers to the depressive syndrome that the patient may have experienced as part of her medical history.)\n##\n(\"relationship\"<|>OBESIDAD MÓRBIDA<|>DIABETES MELLITUS TYPE 2<|>Obesidad mórbida is often associated with diabetes mellitus type 2, as seen in the patient's medical history<|>7)\n##\n(\"relationship\"<|>DEHISCENCIA DE SUTURA<|>BARIATRIC SURGERY<|>Dehiscencia de sutura is a complication that arose from the bariatric surgery<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL TOTAL<|>DEHISCENCIA DE SUTURA<|>Nutrición enteral total was initiated due to the complication of dehiscencia de sutura<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL TOTAL<|>DEHISCENCIA DE SUTURA<|>Nutrición parenteral total was required due to complications following dehiscencia de sutura<|>7)\n##\n(\"relationship\"<|>SOPORTE NUTRICIONAL<|>NUTRICIÓN PARENTERAL TOTAL<|>Soporte nutricional was provided through nutrición parenteral total during the patient's recovery<|>8)\n##\n(\"relationship\"<|>DRA. MARÍA JOSÉ MOLINA PUERTA<|>OBESIDAD MÓRBIDA<|>Dra. María José Molina Puerta treated a patient with obesidad mórbida<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: of impaired\n    nitric oxide production in MELAS syndrome with citrulline and arginine supplementation. Mol Genet\n    Metab. 2012;105(4):607-14.\n\n\n\n    20. El-Hattab AW, Emrick LT, Hsu JW, Chanprasert S, Almannai M, Craigen WJ, et al. Impaired nitric\n    oxide production in children with MELAS syndrome and the effect of arginine and citrulline supple-\n    mentation. Mol Genet Metab. 2016;117(4):407-12.\n\n\n\n    21. Koga Y, Akita Y, Nishioka J, Yatsuga S, Povalko N, Tanabe Y, et al. L-arginine improves the symp-\n    toms of strokelike episodes in MELAS. Neurology. 2005;64(4):710-2.\n\n\n\n    22. Koga Y, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T. MELAS and L-arginine thera-\n    py: pathophysiology of stroke-like episodes. Ann N Y Acad Sci. 2010;1201:104-10.\n\n\n\n    23.   Cynober L. Pharmacokinetics of arginine and related amino acids. J Nutr. 2007;137(6 Suppl\n    2):1646S-1649S.\n\n\n\n    24. Moinard C, Nicolis I, Neveux N, Darquy S, Bénazeth S, Cynober L. Dose-ranging effects of citrulli-\n    ne administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose\n    pharmacokinetic study. Br J Nutr. 2008;99(4):855-62.\n\n\n\n    25. Glover EI, Martin J, Maher A, Thornhill RE, Moran GR, Tarnopolsky MA. A randomized trial of coen-\n    zyme Q10 in mitochondrial disorders. Muscle Nerve. 2010;42(5):739-48.\n\n\n\n    26. Lekoubou A, Kouamé-Assouan A-E, Cho T-H, Luauté J, Nighoghossian N, Derex L. Effect of long-\n    term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an\n    adult MELAS patient. Rev Neurol (Paris). 2011;167(11):852-5.\n\n\n\n    27. Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate\n    in patients with mitochondrial cytopathies. Muscle Nerve. 1997;20(12):1502-9.\n\n\n\n    28. Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA. Beneficial effects\n    of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve. 2007;35(2):235-42.\n\n\n\n54\n---\n   Caso Clínico\nObesidad mórbida, diabetes y cirugía\nbariátrica. Una elección segura, aunque\nno siempre fácil\nDra. María José Molina Puerta\nMédico Especialista en Endocrinología y Nutrición.\nHospital Universitario Reina Sofía, Córdoba.\n\n\n\nResumen\n         Paciente de 48 años con diabetes             mellitus tipo 2, insulinodependiente, mal\ncontrolada y obesidad mórbida refractaria al tratamiento convencional. Es intervenida\nde cirugía bariátrica realizándose un bypass gástrico. En el postoperatorio inmediato,\nse presenta como complicación una dehiscencia de sutura a nivel de la gastroenteroa-\nnastomosis. Se opta por tratamiento conservador de la misma, con colocación de una\nsonda nasoyeyunal quedando la punta de la sonda distal a la anastomosis e inicio de\nnutrición enteral total a través de la misma. La presentación de una hemorragia diges-\ntiva alta y la extracción accidental de la sonda, obligan a iniciar soporte nutricional por\nvía intravenosa con nutrición parenteral total, que se mantiene hasta el cierre definitivo\ndel trayecto fistuloso. El control glucémico durante el ingreso es adecuado y la paciente\nes dada de alta una vez reiniciada la dieta oral y sin necesidad de tratamiento con\ninsulina. Durante el seguimiento ambulatorio, se objetiva remisión parcial de la diabetes\nretirándose todo el tratamiento, con un porcentaje de sobrepeso perdido del 68,9%.\n\n\n\nPalabras clave\n         Cirugía bariátrica, diabetes tipo 2, complicaciones.\n\n\n\nIntroducción\n         Mujer de 48 años intervenida de cirugía bariátrica.\n         Antecedentes familiares: hija con obesidad mórbida.\n         Antecedentes personales: no alergias medicamentosas, no hábitos tóxicos,\nhipertensión arterial (HTA), Hiperlipemia, diabetesmellitus tipo 2 de 12 años de evolu-\nción, sinusitis, artrosis, síndrome depres\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>MELAS SYNDROME<|>EVENT<|>MELAS syndrome is a mitochondrial disorder characterized by stroke-like episodes and impaired nitric oxide production, often treated with arginine and citrulline supplementation.)\n##\n(\"entity\"<|>ARGENINE<|>ORGANIZATION<|>Arginine is an amino acid that has been studied for its effects on improving symptoms in patients with MELAS syndrome.)\n##\n(\"entity\"<|>CITRULLINE<|>ORGANIZATION<|>Citrulline is an amino acid that is used in supplementation to improve nitric oxide production in patients with MELAS syndrome.)\n##\n(\"entity\"<|>DRA. MARÍA JOSÉ MOLINA PUERTA<|>PERSON<|>Dra. María José Molina Puerta is a specialist in Endocrinology and Nutrition, involved in the treatment of a patient with obesity and diabetes.)\n##\n(\"entity\"<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>ORGANIZATION<|>Hospital Universitario Reina Sofía in Córdoba is the medical facility where the bariatric surgery was performed.)\n##\n(\"entity\"<|>BARIATRIC SURGERY<|>EVENT<|>Bariatric surgery is a medical procedure aimed at weight loss, which was performed on a 48-year-old female patient with obesity and diabetes.)\n##\n(\"entity\"<|>DIABETES MELLITUS TYPE 2<|>EVENT<|>Diabetes mellitus type 2 is a chronic condition that affects the way the body processes blood sugar, which was present in the patient prior to surgery.)\n##\n(\"relationship\"<|>MELAS SYNDROME<|>ARGENINE<|>Arginine supplementation is used to improve symptoms in patients with MELAS syndrome<|>8)\n##\n(\"relationship\"<|>MELAS SYNDROME<|>CITRULLINE<|>Citrulline supplementation is used to enhance nitric oxide production in patients with MELAS syndrome<|>8)\n##\n(\"relationship\"<|>DRA. MARÍA JOSÉ MOLINA PUERTA<|>HOSPITAL UNIVERSITARIO REINA SOFÍA<|>Dra. María José Molina Puerta is a specialist at Hospital Universitario Reina Sofía, where she treated the patient<|>7)\n##\n(\"relationship\"<|>BARIATRIC SURGERY<|>DIABETES MELLITUS TYPE 2<|>Bariatric surgery was performed on a patient with diabetes mellitus type 2 to aid in weight loss and improve health<|>9)\n##\n(\"relationship\"<|>DRA. MARÍA JOSÉ MOLINA PUERTA<|>BARIATRIC SURGERY<|>Dra. María José Molina Puerta performed the bariatric surgery on the patient<|>8)\n<|COMPLETE|>"}]}